tiprankstipranks
Trending News
More News >
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Compare Everest Medicines Ltd. (1952) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Everest Medicines Ltd.
HK$51.50
HK$15.78B
-20.35
-6.16%
InnoCare Pharma Ltd.
HK$13.11
HK$19.59B
-92.85
116.69%
5 Buy
1 Hold
0 Sell
Strong Buy
Lepu Biopharma Co. Ltd. Class H
HK$5.14
HK$9.55B
-45.65
98.46%
1 Buy
0 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$15.22B
-52.98
80.37%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$15.10
HK$8.73B
-15.19
67.22%
0 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$10.59B
14.10
-0.74%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1952
Everest Medicines Ltd.
44.62
-2.93
-6.16%
HK:9969
InnoCare Pharma Ltd.
13.11
7.06
116.69%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.14
2.55
98.46%
HK:2162
Keymed Biosciences, Inc.
54.20
24.15
80.37%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.10
6.07
67.22%
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
25.52
-0.19
-0.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts